Surmodics reported $108.39M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Align Technology ALGN:US USD 3.69B 95.54M
Anika Therapeutics ANIK:US USD 284.94M 1.22M
Arrowhead Research ARWR:US USD 398.52M 55.41M
Baxter International BAX:US USD 5.54B 3.32B
Bioscrip BIOS:US USD 1.34B 52.34M
Cryolife CRY:US USD 255.11M 26.4M
Edap Tms EDAP:US EUR 52.26M 1.51M
Edwards Lifesciences EW:US USD 6.22B 274.2M
Haemonetics HAE:US USD 729.01M 41.41M
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Merit Medical Systems MMSI:US USD 1.09B 15.53M
Mesa Laboratories MLAB:US USD 374.24M 6.19M
Nektar Therapeutics NKTR:US USD 412.22M 46.51M
Stryker SYK:US USD 16.46B 789M
Surmodics SRDX:US USD 108.39M 16.72M